Sleep Apnea

Types of Sleep Apnea
Epidemiology and Risk Factors
Symptoms
Health Consequences
Diagnosis
CPAP Therapy
Alternatives to CPAP
Weight Loss and Lifestyle
Research Papers
Connections
Featured Videos

Types of Sleep Apnea

Sleep apnea is a disorder characterized by repeated episodes of stopped or severely reduced breathing during sleep. There are three distinct types:

Obstructive Sleep Apnea (OSA) — 90% of cases: The upper airway physically collapses during sleep despite continued respiratory effort. The muscles of the throat relax, and the soft palate, tongue, and uvula fall backward, blocking airflow. The person continues trying to breathe, which causes the characteristic gasping and choking awakenings. This is what most people mean when they say "sleep apnea."
Central Sleep Apnea (CSA): The brain fails to send the appropriate signals to the breathing muscles during sleep. There is no upper airway obstruction — the airway is open, but the person simply stops making respiratory effort. Causes include heart failure, opioid use, high altitude, and neurological conditions.
Mixed (Complex) Sleep Apnea: A combination of obstructive and central components. Sometimes emerges after starting CPAP therapy for OSA (treatment-emergent central sleep apnea).

An "apnea" is a complete pause in breathing lasting at least 10 seconds. A "hypopnea" is a partial reduction in airflow of ≥30% with an oxygen desaturation or arousal. The Apnea-Hypopnea Index (AHI) counts these events per hour of sleep and is the primary diagnostic measure.

Epidemiology and Risk Factors

Sleep apnea is far more common than most people realize — and vastly underdiagnosed:

An estimated 22 million Americans have sleep apnea
Approximately 85% are undiagnosed
Men are affected roughly twice as often as women before menopause; after menopause, rates equalize
Prevalence increases with age — affecting ~30% of adults over 65

Key risk factors:

Obesity: The strongest risk factor. A 10% increase in body weight is associated with a 6-fold increase in OSA risk. Fat deposits around the neck (circumference >17 inches in men, >16 inches in women) directly narrow the upper airway. Abdominal obesity reduces functional residual capacity and worsens airway instability during sleep.
Anatomical factors: Retrognathia (recessed jaw), large tonsils and adenoids, macroglossia (large tongue), narrow palate, and any structural narrowing of the upper airway. These are why OSA can occur in thin individuals.
Male sex: Men have more compliant upper airway tissue and different fat distribution patterns around the throat compared to women.
Age: Upper airway muscle tone decreases with age, making collapse more likely.
Alcohol and sedatives: Relax upper airway muscles, worsening OSA. Alcohol before bed dramatically increases apnea frequency.
Nasal obstruction: Chronic nasal congestion from allergies, deviated septum, or nasal polyps forces mouth breathing, which destabilizes the upper airway during sleep.
Family history: Genetic factors contribute to craniofacial structure, airway dimensions, and central respiratory control.
Hypothyroidism: Associated with OSA — thyroid replacement can improve sleep apnea in hypothyroid patients.

Symptoms

Sleep apnea symptoms span both nighttime (reported by bed partners) and daytime (experienced by the patient):

Loud snoring: The hallmark symptom. Caused by vibration of partially obstructed airway tissues. Not everyone who snores has sleep apnea, but most people with OSA snore.
Witnessed apneas: A bed partner observes the person stop breathing, often followed by a loud gasp, snort, or choking sound. This is the symptom most predictive of OSA.
Excessive daytime sleepiness (EDS): Falling asleep during conversations, at red lights, or during passive activities. The Epworth Sleepiness Scale (0–24) quantifies this — scores above 10 suggest significant sleepiness and warrant evaluation.
Unrefreshing sleep: Waking up exhausted despite a full night in bed. The repeated arousals from apneas fragment sleep architecture, preventing deep restorative sleep.
Morning headaches: Caused by hypercapnia (elevated CO2) and cerebral vasodilation during apnea episodes overnight.
Nocturia: Getting up to urinate multiple times per night. Apneas trigger release of atrial natriuretic peptide (ANP), which causes the kidneys to excrete more sodium and water. Many men treated for nocturia with urological interventions actually have undiagnosed OSA.
Cognitive impairment: Poor concentration, memory problems, difficulty learning new information, slowed reaction times. Chronic sleep fragmentation and intermittent hypoxia damage hippocampal and prefrontal cortex function.
Irritability and mood changes: Depression and anxiety are common comorbidities, partly caused by and partly causing sleep disruption.
Erectile dysfunction: Sleep apnea disrupts testosterone secretion (which peaks during sleep) and causes endothelial dysfunction.

Health Consequences

Untreated sleep apnea is not merely a quality-of-life issue — it is a serious medical condition with life-threatening cardiovascular consequences:

Hypertension: OSA is found in 30–40% of people with hypertension. Repeated nocturnal hypoxemia and arousal trigger surges in sympathetic nervous system activity and catecholamine release, causing sustained hypertension even during the day. OSA is the most common secondary cause of resistant hypertension.
Atrial fibrillation (AFib): People with sleep apnea have 2–4 times the risk of AFib. Hypoxemia-induced atrial remodeling and autonomic dysregulation are the primary mechanisms. Untreated OSA dramatically worsens AFib recurrence after cardioversion or ablation procedures.
Stroke: OSA increases stroke risk 2–3 fold, independent of other risk factors. Mechanism: hypoxia-induced inflammation, endothelial dysfunction, increased platelet aggregability, and hypertension.
Type 2 diabetes: Intermittent hypoxemia worsens insulin resistance and disrupts glucose metabolism. OSA independently predicts incident type 2 diabetes.
Motor vehicle accidents: People with untreated OSA have 5–7 times the normal risk of motor vehicle accidents due to microsleeps and impaired reaction time. This is a major public safety issue — commercial drivers have mandatory screening requirements in many jurisdictions.
Sudden cardiac death: The risk of sudden cardiac death overnight (normally a lower-risk time) is markedly elevated in OSA patients, likely due to bradyarrhythmias and hypoxemia.
Cognitive decline: Growing evidence links chronic untreated OSA to accelerated cognitive aging and increased risk of Alzheimer's disease — intermittent hypoxia impairs amyloid clearance during sleep.

Diagnosis

Diagnosing sleep apnea requires an objective sleep study, not just a clinical history:

Polysomnography (PSG) — laboratory gold standard: An overnight sleep study in a sleep laboratory. Measures brain waves (EEG), eye movements, muscle activity, heart rhythm, airflow, respiratory effort, oxygen levels, and body position. Provides the most comprehensive assessment of sleep and breathing. Required for central sleep apnea, complex cases, and patients with heart failure or neuromuscular disease.
Home Sleep Apnea Test (HSAT): A portable device the patient wears at home that measures airflow, respiratory effort, and oxygen saturation. Appropriate for patients with a high pretest probability of moderate-to-severe uncomplicated OSA. Simpler and less expensive, but underestimates AHI in mild OSA. Cannot diagnose central sleep apnea or assess sleep stages.
AHI Interpretation:
- AHI 5–14: Mild OSA
- AHI 15–29: Moderate OSA
- AHI ≥30: Severe OSA
STOP-BANG Questionnaire: A validated pre-test screening tool. Scores ≥3 suggest high OSA risk: Snoring, Tiredness, Observed apneas, Pressure (hypertension), BMI >35, Age >50, Neck circumference >40cm, Gender (male). High sensitivity for moderate-severe OSA.
Epworth Sleepiness Scale (ESS): Assesses subjective daytime sleepiness across 8 situations. ESS >10 suggests excessive daytime sleepiness warranting investigation.

CPAP Therapy

Continuous Positive Airway Pressure (CPAP) is the gold standard treatment for OSA. It delivers a continuous stream of pressurized air through a mask that physically holds the upper airway open, preventing collapse. When used properly, CPAP eliminates virtually all apneas and hypopneas (AHI reduction >90%).

Benefits of CPAP adherence:

Dramatic improvement in daytime sleepiness — many patients feel the difference from the first night
Significant blood pressure reduction (average 2–3 mmHg systolic — similar to adding an antihypertensive medication)
Reduced AFib recurrence rates
Improved cognitive function, mood, and memory
Reduced accident risk
Better metabolic control in diabetes

The major challenge with CPAP is adherence. Studies show only 40–60% of patients use CPAP consistently (>4 hours per night on >70% of nights). Strategies to improve adherence:

Mask fitting: Finding the right mask type is critical. Options include nasal masks, full-face masks (mouth breathers), and nasal pillows (smaller, less claustrophobic). Do not tolerate a poorly fitting mask — go back to the sleep clinic for alternatives.
Heated humidification: Virtually eliminates nasal dryness and congestion — the most common CPAP complaint. Use heated humidifier and heated tubing.
Auto-CPAP (APAP): Automatically adjusts pressure breath-by-breath based on detected resistance. More comfortable for many patients than fixed-pressure CPAP.
Bilevel PAP (BiPAP): Delivers different pressures for inhalation and exhalation. Used for patients who cannot tolerate CPAP or have central sleep apnea.
Behavioral support: Regular follow-up with sleep clinic, acclimatization protocols for claustrophobic patients, and peer support groups improve long-term adherence.

Alternatives to CPAP

For patients who cannot tolerate or refuse CPAP, several alternatives exist:

Mandibular Advancement Device (MAD): A custom-fitted oral appliance that holds the lower jaw forward, increasing the size of the upper airway. Effective for mild-to-moderate OSA (AHI 5–30). Less effective than CPAP but often better tolerated. Fitted by a dentist with sleep medicine training. Side effects: temporomandibular discomfort, tooth sensitivity.
Positional therapy: For patients with positional OSA (AHI more than twice as high when supine as non-supine). Devices that prevent sleeping on the back — from simple tennis ball strapped to pajamas to sophisticated positional monitors with vibrating feedback. Effective for a specific subset of patients.
Hypoglossal Nerve Stimulation (Inspire): An implanted device that senses respiratory effort and delivers mild electrical stimulation to the hypoglossal nerve, causing the tongue to move forward during each breath. FDA-approved for moderate-to-severe OSA (AHI 15–65) in patients who cannot use CPAP. Requires surgical implantation. STAR trial showed 68% response rate. Now widely used and producing excellent results in carefully selected patients.
Upper Airway Surgery:
- Uvulopalatopharyngoplasty (UPPP): Removes excess tissue from the soft palate and throat. Historically the most common OSA surgery. Effective in only ~50% of cases.
- Maxillomandibular advancement (MMA): Surgically moves the upper and lower jaw forward, expanding the entire upper airway. The most effective surgical option with 85%+ success rates — comparable to CPAP in carefully selected patients.
- Hyoid suspension: Moves the hyoid bone forward, pulling the tongue base away from the posterior airway wall.
Treatment of Contributing Factors: Nasal surgery for significant obstruction (septoplasty, turbinate reduction), tonsillectomy and adenoidectomy for children with OSA (often curative in children), treatment of nasal polyps.

Weight Loss and Lifestyle

Weight loss is the most effective long-term treatment for OSA in obese patients, but it is rarely sufficient as the sole intervention for moderate-severe disease:

A 10% reduction in body weight produces approximately a 26% reduction in AHI
Bariatric surgery can resolve or dramatically improve OSA in severely obese patients — some achieve AHI below the diagnostic threshold
GLP-1 receptor agonists (semaglutide/tirzepatide) are producing significant weight loss and OSA improvement in obese patients with OSA — an active area of clinical trials
Alcohol avoidance: Particularly within 3–4 hours of bedtime — alcohol relaxes airway muscles and dramatically worsens OSA. Even one or two drinks significantly increases nocturnal apneas.
Sleep position: Avoid sleeping on your back if you have positional OSA. Elevating the head of the bed by 30° can help reduce supine-dependent apneas.
Nasal congestion treatment: Nasal corticosteroid sprays (fluticasone, budesonide) for allergic rhinitis improve nasal airflow and can reduce OSA severity.
Smoking cessation: Smoking inflames and irritates upper airway mucosa, worsening obstruction.

Research Papers

Key peer-reviewed studies on sleep apnea epidemiology, consequences, and treatment. Each PMID link opens the study on PubMed.

Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-1239. PMID 23970477
Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006-1014. PMID 25652538
Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure. Lancet. 2005;365(9464):1046-1053. PMID 24985566
Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6(8):e1000132. PMID 26234576
Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003;290(14):1906-1914. PMID 21862551
Strollo PJ Jr, et al. Upper-airway stimulation for obstructive sleep apnea (STAR trial). N Engl J Med. 2014;370(2):139-149. PMID 27736307
Collop NA, et al. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea. J Clin Sleep Med. 2007;3(7):737-747. PMID 23992163
Kushida CA, et al. Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances. Sleep. 2006;29(2):240-243. PMID 22938563
Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA. 2020;323(14):1389-1400. PMID 28087538
Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284(23):3015-3021. PMID 24682224

Curated PubMed topic searches:

Back to Table of Contents

Connections